Kutlu, M. Et Al. 2023. GLP-1 agonist Liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice. BEHAVIOURAL BRAIN RESEARCH , vol.445 , 114386.

Kutlu, M., Kose, S., & Akillioglu, K., (2023). GLP-1 agonist Liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice. BEHAVIOURAL BRAIN RESEARCH , vol.445, 114386.

Kutlu, MELTEM, SEDA KÖSE KORKMAZ, And KÜBRA AKILLIOĞLU. "GLP-1 agonist Liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice," BEHAVIOURAL BRAIN RESEARCH , vol.445, 114386, 2023

Kutlu, MELTEM D. Et Al. "GLP-1 agonist Liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice." BEHAVIOURAL BRAIN RESEARCH , vol.445, pp.114386, 2023

Kutlu, M. Kose, S. And Akillioglu, K. (2023) . "GLP-1 agonist Liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice." BEHAVIOURAL BRAIN RESEARCH , vol.445, p.114386.

@article{article, author={MELTEM DÖNMEZ KUTLU Et Al. }, title={GLP-1 agonist Liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice}, journal={BEHAVIOURAL BRAIN RESEARCH}, year=2023, pages={114386} }